> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Griffo Botanicals Cited of Covid Product Claims
- URL: https://www.fdaweb.com/griffo-botanicals-cited-of-covid-product-claims/
- Published: 2020-10-09T12:00:00.000Z
- Updated: 2026-09-14T16:31:58.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147841

FDA has sent Griffo Botanicals (Petaluma, CA) a Warning Letter after reviewing the company’s Web site and social media sites and determining that its herbal tincture products are unapproved new drugs because they are being marketed to mitigate, prevent, treat, diagnose, or cure Covid-19\. The agency letter took issue with a number of product claims, such as “Griffo Botanicals has produced four new Covid formulas based on these \[Chinese\] guidelines. The intention of these formulas is to ease symptoms, while bringing the body back into balance.” FDA told the company to take immediate action to correct the cited violations, To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/griffo-botanicals-610434-10072020?ref=fdaweb.com).